Subscribe
Business

Canada approves Merck grass allergy immunotherapy

By The Associated Press
Published
Add Washington Examiner on Google

WHITEHOUSE STATION, N.J. (AP) — Merck & Co. says it’s won its first approval for its new immunotherapy tablet for grass allergies, from regulators in Canada.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.